Waterloo Capital L.P. Has $203,000 Stock Holdings in Cigna Group $CI

Waterloo Capital L.P. lowered its stake in Cigna Group (NYSE:CI) by 24.3% during the second quarter, HoldingsChannel.com reports. The firm owned 614 shares of the health services provider’s stock after selling 197 shares during the period. Waterloo Capital L.P.’s holdings in Cigna Group were worth $203,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Valeo Financial Advisors LLC lifted its stake in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the period. Nuveen LLC acquired a new stake in shares of Cigna Group in the 1st quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its stake in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC grew its holdings in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on CI. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. TD Cowen decreased their target price on Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Truist Financial lowered their price target on Cigna Group from $375.00 to $310.00 in a report on Friday, October 31st. Jefferies Financial Group reiterated a “buy” rating and set a $310.00 price objective on shares of Cigna Group in a report on Monday, November 3rd. Finally, UBS Group set a $294.00 target price on Cigna Group in a research note on Wednesday, November 12th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $334.05.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO David Cordani bought 4,134 shares of the stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Cigna Group Trading Up 2.5%

NYSE CI opened at $278.19 on Wednesday. The company has a market cap of $74.31 billion, a PE ratio of 15.18, a PEG ratio of 0.88 and a beta of 0.44. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a 50 day moving average of $285.92 and a 200-day moving average of $297.87. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.